Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Three-A Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company focuses primarily on anti-infective agents, including a wide range of antibiotics such as cephalosporins and quinolones. With a strong emphasis on Good Manufacturing Practice (GMP) standards, Three-A Pharmaceutical operates significant production facilities in Guangdong province to supply both domestic and international markets. Their product portfolio encompasses tablets, capsules, and injections targeting respiratory, urinary, and gastrointestinal infections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Three-A Pharmaceutical.